Back to company

SIMULPHARMA ApS: Financial statements 2023

CVR: 32832075

SIMULPHARMA ApS (CVR 32832075) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 114,981 and a net result of DKK -57,341 compared with DKK -58,155 the year before. That is a decrease of 76.3% compared with the year before. The profit margin was -49.9%. Equity amounted to DKK 22,477. The solvency ratio was 100%. The company had 1 employee in the financial year.

Revenue
114,981 kr.
Gross Profit
114,981 kr.
Profit/Loss
-57,341 kr.
Equity
22,477 kr.
Total Assets
22,477 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023115 t.115 t.-57 t.22 t.1
2022484 t.406 t.-58 t.80 t.1
2021636 t.636 t.-83 t.138 t.1
2020719 t.719 t.36 t.221 t.1
2019905 t.-15 t.-13 t.185 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

SIMULPHARMA ApS: The 2022 annual report is outJun 5, 2023

SIMULPHARMA ApS has published its annual report for 2022. Revenue came to DKK 484,388, and the net result was DKK -58,155.

About SIMULPHARMA ApS

SIMULPHARMA ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2010. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Gunnlaugur Halldorsson. The company is owned by Gunnlaugur Halldorsson. The company has 1 employee. In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. Equity amounted to DKK 63,769.